Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Maintenance Notification: On Saturday January 19th 2019 (between 22:00 – 02:00 GMT) you will not be able to log into this website due to planned maintenance work.

If you have any questions or concerns, please feel free to reach out to your support team at clientservices@pharma.informa.com

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

P&G Endures 'Top-Line Pain' As Portfolio Streamlining Prioritizes Premium Products

This article was originally published in The Tan Sheet

02 May 2016
News

Lauren Nardella lauren.nardella@informa.com

Executive Summary

The firm reports slumps between 1% and 5% across each of its product categories, but also encourages analysts with reports of sometimes significant progress in its "transformation" initiatives in productivity, portfolio, organization and top-line growth.

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

United States

China

Related Companies

Procter & Gamble Co.

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Consumer United States Middle East and Africa

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS108308

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS108308

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

P&G Endures 'Top-Line Pain' As Portfolio Streamlining Prioritizes Premium Products

News

Executive Summary

Related Content

P&G Eyes Targeted Innovation, China Opportunities Amid Transformation

In Brief: Revlon Sale?; P&G/Coty Fragrance Transfer; More

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert